GeneDx Holdings Corp. (WGS) Operating margin 2019–2025
GeneDx Holdings Corp. (WGS) operating margin by fiscal year — reported operating income divided by reported revenue.
-3.1%FY2025 · since FY2019: -15.5% → -3.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3.1% | +4.5 pp |
| FY2024 | -7.6% | +81.6 pp |
| FY2023 | -89.2% | +195.3 pp |
| FY2022 | -284.5% | -74.2 pp |
| FY2021 | -210.3% | -75.3 pp |
| FY2020 | -134.9% | -119.4 pp |
| FY2019 | -15.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice